Skip to main content

Research Repository

Advanced Search

Reliability and sensitivity to change of the bristol rheumatoid arthritis fatigue scales

Dures, Emma K.; Hewlett, Sarah E.; Cramp, Fiona A.; Nicklin, Joanna K.; Dures, Emma; Hewlett, Sarah; Cramp, Fiona (Alice); Nicklin, Joanna Karen; Greenwood, Rosemary; Urban, Marie; Kirwan, John R.

Reliability and sensitivity to change of the bristol rheumatoid arthritis fatigue scales Thumbnail


Authors

Emma K. Dures

Sarah E. Hewlett

Fiona A. Cramp

Joanna K. Nicklin

Emma Dures Emma2.Dures@uwe.ac.uk
Professor in Rheumatology and Self-management

Fiona Cramp Fiona.Cramp@uwe.ac.uk
Professor in Long Term Conditions

Joanna Karen Nicklin

Rosemary Greenwood

Marie Urban

John R. Kirwan



Abstract

Objective. To examine the reliability (stability) and sensitivity of the Bristol Rheumatoid Arthritis Fatigue scales (BRAFs) and patient-reported outcome measures (PROMs) developed to capture the fatigue experience. The Multi-Dimensional Questionnaire (BRAF-MDQ) has a global score and four subscales (Physical Fatigue, Living with Fatigue, Cognitive Fatigue and Emotional Fatigue), while three numerical rating scales (BRAF-NRS) measure fatigue Severity, Effect and Coping. Methods. RA patients completed the BRAFs plus comparator PROMs. Reliability (study 1): 50 patients completed questionnaires twice. A same-day test-retest interval (minimum 60 min) ensured both time points related to the same 7 days, minimizing the capture of fatigue fluctuations. Reliability (study 2): 50 patients completed the same procedure with a re-worded BRAF-NRS Coping. Sensitivity to change (study 3): 42 patients being given clinically a single high dose of i.m. glucocorticoids completed questionnaires at weeks 0 and 2.Results. The BRAF-MDQ, its subscales and the BRAF-NRS showed very strong reliability (r = 0.82-0.95). BRAF-NRS Coping had lower moderate reliability in both wording formats (r = 0.62, 0.60). The BRAF-MDQ, its subscales and the BRAF-NRS Severity and Effect were sensitive to change, with effect sizes (ESs) of 0.33-0.56. As hypothesized, the BRF-NRS Coping was not responsive to the pharmaceutical intervention (ES 0.05). Preliminary exploration suggests a minimum clinically important difference of 17.5% for improvement and 6.1% for fatigue worsening. Conclusion. The BRAF scales show good reliability and sensitivity to change. The lack of BRAF-NRS Coping responsiveness to medication supports the theory that coping with fatigue is a concept distinct from severity and effect that is worth measuring separately. © The Author 2013. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.

Journal Article Type Article
Publication Date Oct 1, 2013
Deposit Date Aug 20, 2013
Publicly Available Date Feb 11, 2016
Journal Rheumatology (United Kingdom)
Print ISSN 1462-0324
Electronic ISSN 1462-0332
Publisher Oxford University Press (OUP)
Peer Reviewed Peer Reviewed
Volume 52
Issue 10
Pages 1832-1839
DOI https://doi.org/10.1093/rheumatology/ket218
Keywords rheumatoid arthritis, fatigue, patient-reported outcome
reliability, sensitivity, MCID
Public URL https://uwe-repository.worktribe.com/output/937830
Publisher URL http://dx.doi.org/10.1093/rheumatology/ket218
Contract Date Feb 11, 2016

Files







You might also like



Downloadable Citations